Evidence map›Paper›PMID 23332779›Full record

ReviewSeminars in immunology2012

Sensing the immune microenvironment to coordinate T cell metabolism, differentiation & function.

Emily B Heikamp, Jonathan D Powell

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Divide, Conquer, and Sense: CD8Frontiers in immunology · 2016
    Article
  5. Article
  6. Article
  7. Mechanisms and applications of interleukins in cancer immunotherapy.International journal of molecular sciences · 2015
    Review
  8. Harnessing FOXP3+ regulatory T cells for transplantation tolerance.The Journal of clinical investigation · 2014
    Review
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Emily B HeikampSidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, United States.
Jonathan D Powell
Cancer Research Center · USSidney Kimmel Comprehensive Cancer Center · US

Funding

CELLULAR &MOLECULAR MECH OF INFLAMMATORY REACTIONST32AI007247 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Joel L Pomerantz · 1985 to 2026
$10.2M
A central role for mTOR in Determining T Cell Activation versus ToleranceR01AI077610 · NIAID · JOHNS HOPKINS UNIVERSITY · PI POWELL, JONATHAN D · 2009 to 2019
$4.0M
Transplantation tolerance and immune function following mTOR inhibition.R01AI091481 · NIAID · JOHNS HOPKINS UNIVERSITY · PI POWELL, JONATHAN D · 2010 to 2013
$1.6M
NIAID NIH HHS AI791481NIAID NIH HHS R01 AI077610NIAID NIH HHS R01 AI091481NIAID NIH HHS R01 AI77610NIAID NIH HHS T32 AI007247
6 · The paper itself

Abstract

Mounting an adaptive immune response is bioenergetically demanding. As a result, T cell activation coincides with profound changes in cellular metabolism that must be coordinated with instructive signals from cytokine and costimulatory receptors to generate an immune response. Studies examining the intimate link between metabolism and immune function have revealed that different types of T cells have distinct metabolic profiles. Data is emerging that place mTOR, an evolutionarily conserved serine-threonine kinase, as a central integrator of these processes. In this review, we will discuss the role of mTOR in determining both CD4 and CD8 T cell metabolism, differentiation, and trafficking.

Indexed as

AnimalsCell DifferentiationGene Expression RegulationHumansLymphocyte ActivationMiceSignal TransductionT-LymphocytesTOR Serine-Threonine KinasesMTOR protein, humanTOR Serine-Threonine Kinases

Identifiers

PMID23332779
PMCPMC3582714
OpenAlexW2079996300

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.